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Abstract
Microbeam radiation therapy (MRT) is a promising experimental and preclinical radiotherapy
method for cancer treatment. Synchrotron based MRT experiments have shown that spatially
fractionated microbeam radiation has the unique capability of preferentially eradicating tumour
cells while sparing normal tissue in brain tumour bearing animal models. We recently
demonstrated the feasibility of generating orthovoltage microbeam radiation with an adjustable
microbeam width using a carbon nanotube based X-ray source array. Here we report the
preliminary results from our efforts in developing an image guidance procedure for the targeted
delivery of the narrow microbeams to the small tumour region in the mouse brain. Magnetic
resonance imaging was used for tumour identification, and on-board X-ray radiography was used
for imaging of landmarks without contrast agents. The two images were aligned using 2D rigid
body image registration to determine the relative position of the tumour with respect to a
landmark. The targeting accuracy and consistency were evaluated by first irradiating a group of
mice inoculated with U87 human glioma brain tumours using the present protocol and then
determining the locations of the microbeam radiation tracks using γ-H2AX immunofluorescence
staining. The histology results showed that among 14 mice irradiated, 11 received the prescribed
number of microbeams on the targeted tumour, with an average localization accuracy of 454 μm
measured directly from the histology (537 μm if measured from the registered histological
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images). Two mice received one of the three prescribed microbeams on the tumour site. One
mouse was excluded from the analysis due to tissue staining errors.
1. Introduction
Radiation therapy (RT) and surgery are the most effective treatment modalities for tumour
local control. Today more than half of all the cancer patients in North America rely on RT as
part of their cancer management. Despite its undeniable cell killing power, RT is not always
successful. This is due to the fact that the radiation dose required for tumour eradication
often causes intolerable acute and/or long-term damage to surrounding normal tissue.
Microbeam radiation therapy (MRT) is an experimental and preclinical radiosurgery method
for cancer treatment. The technique was first developed at the Brookhaven National
Laboratory (Upton, New York, USA) (Slatkin et al 1992, Slatkin et al 1995, Laissue et al
1998) and the European Synchrotron Radiation Facilities (Grenoble, France) (Thomlinson et
al 2000, Laissue et al 1999). In this technique highly directional and high flux synchrotron
radiation is spatially fractionated into quasi-parallel and microscopically thin planar X-ray
beams. Synchrotron-generated X-ray microbeams are usually 25 – 75 μm in width, with
centre-to-centre distances of 100 – 200 μm (Dilmanian et al 2003, Serduc et al 2009b), as
illustrated in figure 1. The resulting radiation dose distribution has characteristic peaks and
valleys with an extremely high peak-to-valley-dose-ratio (PVDR). A single radiation dose of
up to 103 Gy, which is two orders of magnitude higher than what is commonly used in the
accelerator based RT, is administrated within a second (Slatkin et al 1995). Brain tumour
bearing animal model studies have shown that MRT has the unique capability of
preferentially eradicating malignant tumours and extending the survival time while sparing
the normal tissues irradiated by the same extremely high dose radiation. Although the
normal tissue sparing and therapeutic efficacy of MRT have been demonstrated in duck
embryos (Dilmanian et al 2001), mice (Dilmanian et al 2003, Miura et al 2006, Serduc et al
2006, Serduc et al 2008a, Serduc et al 2008b), rats (Slatkin et al 1995, Laissue et al
1998,Dilmanian et al 2002, Zhong et al 2003, Smilowitz et al 2006, Regnard et al 2008,
Laissue et al 2013), and weanling piglets (Laissue et al 2001, Laissue et al 2007), this
promising treatment technology has not yet been translated to the clinic.
The overall therapeutic effect of MRT is a compromise between tumour control and normal
tissue sparing (Serduc et al 2009a). Thicker microbeams induce more tumour tissue damage,
but would also increase the risk of toxicity to normal tissue (Zeman et al 1961, Curtis 1967,
Serduc et al 2009a). Experimental studies have shown that normal tissue sparing effect is
preserved even when using a microbeam with a beamwidth of up to several hundred microns
(Dilmanian et al 2005, Dilmanian et al 2006) as long as the valley doses were kept under the
threshold values, such as in the so called minibeam radiation therapy (MBRT). Also
investigated at the synchrotron facilities, MBRT uses X-ray with beamwidth typically
around 500 – 700 μm, about 10 times wider than the typical synchrotron MRT beam.
Thicker beams are less vulnerable to beam smearing from cardio-synchronous brain tissue
pulsation and will also relax the mechanical tolerance requirements for more complex MRT
geometries, such like cross-hatching and interlaced cross-firing (Dilmanian et al 2006). Both
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in vitro and in vivo studies of MBRT have shown evidence of cell killing and lifespan
increase (Gil et al 2011, Prezado et al 2009, Prezado et al 2012).
Various theories have been proposed to explain the normal tissue-sparing and tumour cell
ablation effects of MRT. Work done by Serduc et al. has shown the preferential effect of
MRT on tumour blood vessels, leading to tumour hypoxia and eventually necrosis, while
normal brain tissue vasculature exposed to MRT was found mostly undamaged and
sufficiently perfused to prevent any hypoxia (Serduc et al 2006, Bouchet et al 2010,
Bouchet et al 2013). Dilmanian et al., in several in vitro studies, showed evidence of the
bystander effect for tissue restoration (Dilmanian et al 2007). However, there is no
conclusive theory that fully explains the biology of MRT. So far all reported MRT
experiments were carried out at large and high cost synchrotron facilities. Two main
possible alternative radiation sources are the megavoltage LINAC and conventional
orthovoltage tubes. However, the megavoltage LINAC used in conventional RT cannot be
used for MRT because the large number of scattered, secondary charged particles created in
the tissue would substantially increase the beam penumbra and smear out the microbeam
patterns. Moreover, it has been found that extremely large peak doses (> 100 Gy) are
required to completely ablate aggressive tumours for which this technique would be best-
suited (Anschel et al 2010). Obtaining such high doses within feasible time scales is difficult
using conventional orthovoltage X-ray tubes due to the anode thermal limitations. The
smaller the focal spot size the lower the output power. Most conventional orthovoltage tubes
have a large focal spot (usually 1-10 mm) generating a broad and divergent beam that cannot
be readily used for MRT. A collimator with a narrow opening and very large aspect ratio is
needed to collimate the intrinsically divergent beam to obtain the desired microbeam pattern
with efficiently high PVDR. In this geometry X-ray photons originated from most of the
focal area do not pass through the microbeam collimator and the actual microbeam dose rate
delivered is largely reduced. Although micro-focused orthovoltage X-ray tubes are
commercially available, they operate at much lower power. In contrast to its alternatives,
synchrotron generated X-ray radiation has minimal angular divergence and therefore can be
readily collimated into parallel micro-planar beams. Ultra-high dose rates allow for
instantaneous delivery of high doses to maintain the microbeam profile despite physiological
motion. The reliance on synchrotron radiation, however, has hindered more widespread
research on this promising approach for cancer treatment and is a major roadblock for
translation into clinical applications.
We recently developed a spatially distributed X-ray source array technology using the
carbon nanotube (CNT) field emitters as a “cold cathode” (Zhou and Lu 2003, Zhang et al
2005, Zhou and Calderon-Colon 2010). The CNT cathode emits an electron beam under an
applied electric field, which is then accelerated to bombard the metal anode to generate X-
rays. Compared to a conventional thermionic X-ray tube, where the radiation is generated
from a single focal point on the anode, the field emission technology affords greater
flexibility in the source design in terms of the dimension, number of sources, geometric
configuration of the individual source, and the mode of operation. By sequentially switching
on and off the individual and spatially distributed sources, a “scanning” X-ray beam can be
generated to image an object from different viewing angles without mechanical motion,
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which enables fast and high-resolution tomography imaging. This has been demonstrated in
stationary digital tomosynthesis for imaging the breast (Qian et al 2012) and chest (Shan et
al 2013), tomosynthesis-guided radiation therapy (Maltz et al 2009), and stationary
computed tomography (Gonzales et al 2013). To obtain a higher X-ray flux, all or a subset
of the X-ray sources can be switched on at the same time to irradiate an object from different
directions. The field emission X-ray source can be electronically switched on and off by
controlling the emission current from the CNT cathode, and can be readily gated with
physiological signals for prospective imaging (Cao et al 2009, Cao et al 2010).
Utilizing the unique capabilities of the CNT X-ray source array technology we recently
demonstrated the feasibility of generating orthovoltage microbeam radiation (Zhou and
Chang 2010, Schreiber and Chang 2012, Hadsell et al 2013). The prototype device utilized a
specially designed CNT X-ray source array with a long and narrow focal track to deliver the
radiation simultaneously from different directions, instead of from a single point, to the
region of interest. An external collimator was used to collimate the radiation into a
microbeam of adjustable beamwidth. A higher dose rate was achieved by distributing the
electron energy over the long focal tracks with increased heat capacity compared to
conventional point-focus X-ray tubes. The electronically controlled field emission of the
electrons and resultant X-ray generation enabled accurate and reliable delivery of the
radiation, and also allowed for physiologically gated irradiation which minimizes motion-
induced blurring of the microbeam pattern (Chtcheprov et al 2013). Minimal motion-
induced blurring is critical for non-synchrotron based MRT with an inevitably longer
treatment time. The irradiator was integrated with a CNT-based micro-CT scanner (Cao et al
2010) for image guidance. To increase the treatment throughput, special mouse beds were
designed to allow irradiation of two mice simultaneously, with independent anaesthesia and
physiological monitoring capabilities. At full power, this first generation system can deliver
an instantaneous dose rate of 2 Gy/s at the entrance plane with a PVDR of over 17 (Hadsell
et al 2013).
The goal of this study is to evaluate an image-guidance protocol for targeted delivery of
microbeam radiation to mouse brain tumours. Because tumours are usually located deep
inside the mouse brain, and small in size (~2 mm in diameter), it is technically challenging
to accurately align the narrow microbeams with the small tumour volume. X-ray and CT
imaging can quickly capture bone structures but are not ideal for brain tumour imaging due
to low soft tissue contrast, even with a considerable dose of contrast agent. Contrast agent
increases toxicity risk to the animal and complicates the treatment outcomes. Magnetic
resonance imaging (MRI) provides good tumour tissue contrast non-invasively, but needs to
be performed at a separate location. Throughout the course of this study we investigated a
hybrid image-guidance protocol that combines MRI with on-board 2D X-ray radiography in
order to identify the tumour location with respect to the microbeam position, to ensure
accurate dose delivery. We evaluated the accuracy and consistency of this protocol using
brain tumour mouse models and characterized the cell responses to radiation using γ-H2AX
immunofluorescence staining. Stained tissue slices produced clear patterns of tissues’ DNA
damage corresponding to the microbeam path and spatial arrangements, which were used to
estimate the targeting accuracy.
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2. Methods and materials
2.1. The compact image-guided MRT system
As shown in figure 2, the prototype image-guided MRT system consists of a CNT field
emission X-ray source array irradiator and a high-resolution micro-CT scanner. The X-ray
irradiator consists of a linear CNT field emission cathode array, which emits electrons under
a biased extraction field, an electrostatic focusing lens and an opposing stationary tungsten
anode. The electron beam is focused down to a narrow focal line on the reflective anode
measuring approximately 0.142 mm in width and 160 mm in length after projection at an
angle of 8°. The X-ray source array is operated at 160 kVp anode voltage and 30 mA tube
current. The intrinsically divergent line of radiation is collimated into a microbeam using a
motorized slit collimator placed between the X-ray window and the object, as shown in
figure 3. Parallel planes of microbeam irradiation are generated by translating the object in
the direction perpendicular to the microbeam plane in a step-and-shoot fashion. For this
study, a 280 μm wide (determined via film measurements at the entrance plane during tube
dosimetric characterization) microbeam was used.
The homemade micro-CT scanner is composed of a micro-focused CNT field emission X-
ray source (XinRay Systems Inc., NC) with an effective focal spot size of 100 μm × 100 μm,
and an operating anode voltage of up to 50 kVp. In addition, the system contains a 5 cm × 5
cm flat panel detector (Hamamatsu C7921CA-02), with a pixel size of 50 μm × 50 μm,
mounted on a rotating gantry (Cao et al 2010). The isocentre of the micro-CT scanner is
aligned with the irradiator’s microbeam entrance location on the mouse head. Two
customized mouse holders were fabricated by 3D printing as shown in figure 4. The holders
were designed to accommodate the head-immobilizing hardware, the anaesthesia tubing and
the respiration sensor. The head-immobilizing hardware consists of two ear bars that can be
fastened securely to hold the mouse head in a non-rotated and non-tilted position in order to
achieve accurate image registration with MRI. The nose cone holds the isoflurane-in and
exhaust-out tubing in place, and supports the mouse head at a proper height. The respiration
rate was monitored by the pressure sensor underneath the abdomen of the mouse, from
which the signals were visualized and recorded on the Biovet (m2m Imaging Corp., OH)
user interface throughout the entire procedure. High precision translation stages (Velmex
Inc., NY) transport the animals from the imaging site to the irradiation location. The stages
(Velmex Inc., NY) have a line accuracy of 76 μm. The actuators (Newport Corp., CA), used
for adjusting the relative positions of the two mouse beds, have on-axis accuracy of ~ 10
μm.
2.2. Dosimetry
Dosimetry of this compact MRT prototype was performed using Gafchromic EBT2 film
(Ashland Advanced Materials, Covington, KY, US) calibrated to an ion chamber
(RadCalTM 10X5-0.6CT Farmer-type, with a MDH-1015C control unit. The Gafchromic
EBT2 film was chosen due to its weak energy dependence in the 60 keV to MeV range
(Arjomandy et al 2010), high sensitivity in the 0 - 100 Gy dose range, and high spatial
resolution (Andres et al 2010). The film was calibrated by benchmarking the measured
output of the ion chamber irradiated in the uncollimated beam to the response of the film
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under the same conditions. Eleven film swatches were irradiated with doses ranging from
0-56 Gy as measured by the ion chamber. These films were scanned using a Perfection
V700 flatbed scanner (Epson America, Long Beach, CA) in 48-bit color and 72 dpi. Finally,
the raw scanner response values for all three color channels were fitted to the known dose
values using a rational function as recommended by Ashland, Inc. (Hadsell 2013).
The dose rate at the typical source to surface distance of 124 mm for our in-vivo
experiments was determined based upon Gafchromic EBT2 film measurement as well.
These measurements were performed by irradiating EBT2 film with several microbeams
delivered using various beam-on times, all using the same machine settings presented in this
work. The film was scanned at 2400 dpi, and the peak dose for each microbeam was
measured using single channel (green) dosimetry in FilmQAPro (Ashland Advanced
Materials, Covington, KY US). The peak doses were then plotted against the beam-on time
used for each microbeam and fit by a linear regression. The average dose rate was found to
be 1.16 Gy/min at 124 mm from the focal line, with the tube operating at 8% duty cycle
(Hadsell 2013). Based on this value, the dose rate exiting the microbeam collimator was
then extrapolated using previously measured tissue maximum ratio (TMR) and distance
correction tables to be 2.42 Gy/min.
For this study, Gafchromic EBT2 films were placed at the entrance and exit planes of the
mouse head during the radiation to qualitatively verify the gross positioning of the mouse
and proper beam delivery. All films were scanned in 48-bit color and at 2400 dpi using the
same V700 scanner according to the recommended handling procedures of Ashland, Inc.
The film scans were then analyzed using the calibration curves described above and multi-
channel film dosimetry (Micke et al 2011, van Hoof et al 2012) as implemented by
FilmQAPro. Due to the upper limit of our calibration curve, only those verification films
from treatment plans with dose levels within the 0 – 60 Gy range were scanned and analyzed
to create dose profiles. These dose profiles were then compared with the prescribed
treatment plans, i.e. verifying expected peak dose, beam width, and beam separation.
2.3. Mouse model and mouse handling
Experimental procedures carried out in this study were approved by the Institutional Animal
Care and Use Committee at our institution. Fourteen young adult (4 - 6 weeks old), male,
athymic nude mice were used for this tumour-targeting MRT experiment. U87MG human
glioma tumour cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) plus
1% Fetal Bovine Serum (FBS) before being collected for injection. Three weeks before
irradiation, and with stereotactical guidance, 2 × 105 cells in 5 μl serum-free medium were
injected intracranially into the right forebrain — 1mm anterior, 2.5 mm lateral, and 4 mm
down to the bregma — to induce brain tumour growth in the mouse. For all imaging and
MRT treatment procedures, the mice were anesthetized with 1% - 2.5% isoflurane in
medical-grade oxygen at 0.8 or 1 L/min flow rate.
2.4. MR and X-ray imaging
The image-guided MRT protocol is outlined in chart 1. One day before radiation treatment,
mice were brought to the imaging facility (Biomedical Research Imaging Centre, UNC-
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Chapel Hill) for MRI with a 9.4 Tesla MR scanner (Bruker BioSpin, Inc. Billerica, MA).
T2-weighted images were acquired using a Rapid Acquisition with Refocused Echoes
(RARE) sequence with an echo spacing-to-recovery time ratio (TE/TR) of 22/3406, 256 ×
256 matrix size, 0.5 mm slice thickness, and 100 micron sagittal and coronal in-plane
resolution. The tumours ranged in diameter from 1.5 mm to 2.1 mm were delineated in T2w
images with hyper-intense signal. The MR images used for registration were created from
the sagittal images. The central three slices near the brain midline were averaged to form a
sagittal projection image. This projection was later used to align with the sagittal X-ray
projection of the same mouse. The tumour location was projected to the centre slice.
After MRI, the mice were transported to the MRT lab on the day of irradiation. While under
anaesthesia, the mice were first immobilized in the prone position on the customized
holders. The ear bars, nose cone and the teeth clamping altogether ensured immobility of the
sedated mice. Two mice were immobilized on two separate mouse beds, which were then
mounted side by side on translation stage (figure 5 top). X-ray projections of the two mice
were taken using the micro-CT scanner at 45 kVp and 0.024 mAs per projection. Imaging of
the mice was performed one at a time in an image-and-shift manner, as illustrated in figure 5
(middle and bottom). The actuator and micrometer attached to the mouse bed positioned the
head of the mouse being imaged at the centre of the detector field of view, while the other
mouse was kept outside of the X-ray beam pathway. X-ray projections were acquired from
the same orientation (sagittal view) as that in the MRI. Afterwards the mouse imaged first
was shifted out from the field of view; the other was moved in, and imaged in the same
manner. The projections were corrected with dark and blank images using a MATLAB
(MathWorks Inc., Natick, Massachusetts, US) program. For X-ray imaging, the ear bars on
the mouse holder were used as the fiducial landmarks because they were easily calibrated to
both the microbeam position and the brain structures of the mouse.
2.5. Image registration
The sagittal MR images and corrected X-ray images were scaled to the same pixel size, and
aligned manually using Photoshop (Adobe Systems Inc., San Jose, California U.S.) and
ImageJ (Public Domain, Developed by Wayner Rasband, NIH) using rigid-body registration
method. Skull contours were identified on both MR and X-ray images, and then aligned
together. Once the images were registered, the relative distance from the tumour centre to
the ear bars, Δx1, was calculated from the registered images in both anterior-posterior and
superior-inferior directions, as shown in figure 6. Since the two ear bars may not be
concentric in the projection images depending on their location in the image and the
differences in magnification, the midpoints of two ear bars were averaged and used as the
‘centre of ear bar’. The microbeam planes transversely intersect with the mouse brain at a
slight angle of 8 degrees (collimator angle), as shown in figure 7 on the left.
2.6. Microbeam alignment and irradiation
Figure 6 shows the geometrical parameters that need to be determined in order to accurately
deliver the microbeam to the tumour. Since the planar microbeams are delivered in the y-z
plane and no conformal collimation is used in the current setup, only the relative distances in
the x direction are needed. To determine the microbeam entrance position with respect to the
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ear bars, a piece of Gafchromic film was placed on the top surface of the mouse holder, and
translated into the MRT chamber with the travel distance, Δx2, being recorded. A low dose
single microbeam was delivered on the film for calibration purposes. The distance between
the centre of the microbeam to the ‘centre of ear bars’, Δx3, was measured with the use of a
pair of calipers. Using the tumour location relative to the ear bars, Δx1, determined from
registration, the distance between the tumour and the microbeam entrance point for the mice
pair was therefore calculated by the summation of Δx1, Δx2, and Δx3, with the signs
assigned accordingly.
After imaging, the mice were translated from the imaging location to the irradiation site,
ready for treatment. The number of microbeams, beam pitch, and the beam delivery
locations on the tumour site, were decided based on the registered image and tumour size.
For this targeting study, we chose various dose levels and different numbers of microbeams
for the animals (as assigned below), which was also investigated in another study for cellular
responses. The microbeam irradiator was running at a constant anode voltage of 160 kV,
producing a microbeam of 280 μm full-width-half-maximum (FWHM) at the animal head
entrance plane. The average dose rate at the entrance plane was 1.16 Gy/min, determined as
noted before. In total, fourteen tumour bearing mice were irradiated in seven groups, two
mice at a time following the procedures described above, as shown in figure 7.
The first pair of mice was irradiated by a single microbeam of 138 Gy entrance dose,
targeted at the centre of the tumour. The second pair of mice was irradiated by two parallel
microbeams with centre-to-centre distance of 900 μm. A 900 μm centre-to-centre distance
was chosen to maintain a relatively high PVDR with 280 μm beamwidth, and to achieve
good coverage of the tumour area. The prescribed entrance dose for each microbeam was
about 108 Gy. Between the two microbeams, the first was targeted at the centre of the
tumour while the second was targeted 900 μm away. The remaining 5 pairs of mice were
irradiated by three microbeams, with a 900 μm pitch, delivering 48 Gy at the entrance of
each microbeam.
2.7. Immunohistological confirmation
To evaluate the targeting accuracy and the tumour cell response, γ-H2AX
immunofluorescence staining was used as a quantitative biomarker of radiation-induced
DNA double-strand breaks (DSB). This process confirms the delivery of microbeams
through the tumour tissue sections post irradiation. The mice were euthanized at various
time points (1 hr, 4 hrs, 24 hrs, 48 hrs, and 7 days) post-MRT. Their brains were collected
and fixed in formalin. The fixed brains were cut in half along the midline and embedded in
paraffin. Before tissue sectioning, the distance between the centre midline to the targeted
tumour plane in the sagittal view that was used for treatment planning was first measured
from both coronal and sagittal MR images. This distance was then used in sectioning to
determine the tumour location on the paraffin-embedded brain hemisphere, taking into
account a 20% shrinkage rate from the dehydration process (Winsor 1994). Ten, 5 μm
sections were cut in the sagittal plane, perpendicular to the microbeams, near the target
locations. One of the sections was used for γ-H2AX staining. The staining procedures
followed the published protocol (Crosbie et al 2010). Briefly, the tissue section was de-
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paraffinated, rehydrated, antigen-demasked by citrate buffer, and then incubated with the
primary antibody (Phosphohistone H2AX Rabbit anti-mouse antibody, Cell Signaling
Technology Inc.) for 60 min. This was followed by incubation with the secondary antibody
with Cy5 Tyramide and DAPI counter-staining on the nuclei. The section was then scanned
using a fluorescence slide scanner system (Scanscope FL scanner, Aperio Inc., Vista, CA) to
obtain a whole brain slide image.
3. Results
3.1. MR and X-ray images and registration
A typical set of MR, X-ray projection and registered images is shown in figure 8. The 2-D
shape, size and location of the tumour can be clearly visualized in the MR image. The
average tumour size was measured to be approximately 1.4 × 2.2 mm2 on the sagittal plane,
with the tumour centre marked out. In the corrected X-ray projection, the primary bone
structures including the skull features, jaw, and spinal cord, the ear bars and the anaesthesia
tubing on the mouse holders were well displayed. The registered image combined
information from both the MR and X-ray images, showing both the tumour and the ear bars.
From the registered image, the relative distance along the x-axis between the centre of the
tumour and the ear bars was measured.
3.2. Verification of beam delivery
Gafchromic films were placed at the entrance and exit planes of mouse head for qualitative
verification of beam delivery. All films were scanned in 48-bit color and at 2400 dpi using
the V700 scanner following the handling procedures recommended by Ashland, Inc.
Number of beams and c-t-c distances were confirmed in all films to be consistent with the
prescription. The films irradiated by planned doses that fell into 0 - 60 Gy dose range were
analyzed using triple channel dosimetry in FilmQAPro. Figure 9 shows the results of the
analyzed films from a tumour mouse treated with three microbeams with dose of 48 Gy/
beam. The FWHM of the dose profile was measured to be 280 μm at the entrance plane,
which was consistent with our tube calibration results. The beam width broadened to 380 μm
at the exit plane underneath the mouse skull. The measured peak dose of each beam was
consistent with the prescribed value as well. The PVDR was calculated as,
(1)
Dpeak and Dvalley are the average doses measured at the centre of peak, and the centre of
valley respectively. The average PVDR was calculated to be 16 +/-1 at the entrance plane,
and reduced to 14 +/-1 at the exit plane.
3.3. Immunohistological confirmation
Figure 10 shows the γ-H2AX stained images of the irradiated mouse brain slices. The γ-
H2AX foci-positive cells shown as pink strips were clearly visible in the stained sections
indicating radiation-induced DNA double-strand breaks. These patterns corresponded to the
microbeam path and spatial arrangements through the tumour and normal tissues. The
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geometric centre-to-centre distance between two adjacent tracks was measured to be 800
μm, which matches with the prescribed beam pitch of 900 μm when taking into account the
average 20% anisotropic shrinkage rate (Winsor 1994) of the paraffin embedded slice.
The targeting error was first evaluated directly from the stained sagittal sections by
measuring the horizontal displacement, Δx, from the centre of the microbeam to the centre
of the tumour. Out of the 14 animals in this study, one animal was excluded due to cutting
and staining mistakes. The average horizontal displacement Δx of the remaining 13 mice
was approximately 454 μm. The values measured via this manner are listed in column 2 of
table 1.
Since the MR images were taken the day before MRT and the animals were euthanized at
different time points post MRT, there might have been anisotropic tumour growth between
the MRI and euthanization. This created difficulties in identifying the original target centre
in the stained section. The targeting accuracy was also evaluated by manually registering γ-
H2AX stained image back to the corresponding pre-treatment MR sagittal images, as shown
in figure 1. The γ-H2AX stained image recorded the microbeams’ positions while the MR
sagittal image showed the original targeted tumour centre. This alignment method is similar
to the X-ray/MR image registration mentioned previously in this paper, except that here we
used features in the brain and cerebellum instead of skull contour for alignment. The
targeting errors Δx measured in this way are listed in column 3 of table 1.
4. Discussion and conclusions
In total, 14 animals were irradiated using the combined X-ray/MRI image-guided MRT
protocol described above. Due to tissue sectioning and staining errors, one mouse was
excluded from the analysis. The histology data showed that 11 out of the remaining 13
animals successfully received all of the prescribed number of microbeams on the targeted
tumours. The other two mice received one out of the three planned microbeams at the
primary tumour site while the other 2 microbeams were delivered outside the targeted
tumour location. One of these two mice with misplaced microbeams had a relatively small
tumour size (<1.4 mm) along the beam array direction, considering the centre-to-centre
spacing used in this study was 900 μm. It is noticed that one of the two mice (Animal ID
1086), which was irradiated with a single high dose microbeam, showed a relatively high
error (in both error calculation methods) compared to the rest of the mice. The respiratory
pattern recorded by the Biovet monitoring program indicated that this animal experienced
multiple substantial gasps during the irradiation. This could have caused body movement or
loosening of the ear bars, leading to the reduced targeting accuracy for this specific animal.
Regardless, the results for these two mice were included in the estimation of the targeting
error.
There are several potential sources of error in the present procedure including uncertainties
in the registration of MR and X-ray images, and consistency in positioning the mouse. First
of all, since MR and X-ray images were taken at different facilities, there were
transportation and re-positioning of animal from one facility to another. Even though
immobilized using the same type of mouse holders and imaged from the same direction, the
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animals were not positioned exactly the same for MR and X-ray imaging. The variations in
orientation of the mouse eventually led to variations in the images. Secondly, the features
used for image matching were not perfectly sharp and the images were collected at a finite
resolution, both of which contributed to the targeting error observed in this study. Besides,
the large tissue shrinkage and deformation not only made it hard to manually align the
stained tissue section to the MR image, but it also degraded the accuracy of any
measurement from the stained slice.
Another source of uncertainty comes from the mouse head immobilization and anaesthesia
during irradiation. In our customized mouse holder design, the teeth clamping wire, nose
cone, and the ear bars altogether should provide sufficient immobility during irradiation
providing that the animals were put under anaesthesia. However, if the animal experienced
substantial gasping during RT, such as what has happened to mouse ID 1086, drastic body
motion or even loosening of the ear bars and teeth clamp could lead to animal dislocation
and microbeam being delivered off-target.
The microbeam delivery accuracy obtained in the present study is comparable with the
targeting accuracy reported in the literature for image-guided small animal irradiators
(Verhaegen et al 2011). Matinfar et al. showed an error of 0.2 mm in beam alignment when
irradiating a radio-opaque marker in a rigid phantom using an in-house small animal
radiation research platform (SARRP) (Matinfar et al 2009), and an average displacement in
mouse repositioning of 0.8 +/− 0.49 mm using this system was reported in a separate study
(Armour et al 2010). Another commercially available small animal irradiation device, X-
Rad 225Cx (PXI, North Branford, CT) claimed an image-guidance accuracy of no larger
than 0.5 mm, and the study on this device by Clarkson et al. concluded a consistent accuracy
on the order of 0.2 mm in targeting the centre of a metal BB fixed to radiochromic film
(Clarkson et al 2010). The small animal research system adapted from a micro-CT at
Stanford University achieved 0.1 mm accuracy in each direction using a solid water
phantom containing a metal sphere (Zhou et al 2010). A distinction must be made when
comparing the image-guidance performance of our system to other small animal IGRT
systems is the target objects used in the evaluation. In this study, the accuracy level was
quantified in vivo – targeting the mouse brain tumour which usually has no well-defined
structure and no sharp, clear edges, whereas in other systems it was evaluated using rigid
phantoms with unambiguous margins. In addition to the higher requirement in image quality
for brain tumour visualization, the respiration-induced brain motion in the animal during
imaging and irradiation posed more challenges for our evaluations compared to rigid
phantom studies. On the other hand, all other preclinical IGRT systems generally operate at
too large of a field size with large beam penumbras, making them not suitable for MRT. For
example, the smallest field size that the SARRP can produce is 500 μm, at which the system
can only provide a dose rate of up to 22 cGy/min at 1 cm depth in water (Wong et al 2008).
And even then, the 20-80% penumbra is almost 0.2 mm on each side (Wong et al 2008). So
far, the system presented in this study is the only one capable of generating microbeams of
relevantly high dose rate for small animal studies (Verhaegen et al 2011), with a PVDR well
within the range of Synchrotron MRT (Anschel et al 2010).
Zhang et al. Page 11






















On-board image guidance was not implemented in most of the synchrotron MRT
experiments. To ensure tumour coverage the conformal microbeam radiation delivered
typically covers a much larger area (typically in the order of 10 mm × 10 mm) than the size
of the brain tumour, by mechanically scanning the mouse mounted on a precision
goniometer through the microbeam arrays in a fraction of a second. For such size irradiation
fields, Laissue et al. estimated that the ratio of the tumour volume to the total brain volume
covered by microbeam arrays was only about 0.06, and therefore a very large amount of
normal brain was enclosed in the target volume where the heaviest damage was seen
(Laissue et al 1998). Planar X-ray imaging was utilized in several recent studies to either
identify the tumour cell injection point (Romanelli et al 2013) or to locate specific skull
landmarks for homogenous irradiation of brain regions (Serduc et al 2010) without direct
localization of the actual tumour to be treated. This is because planar X-ray by itself cannot
readily visualize brain tumour without using high concentration of X-ray contrast agent due
to the limited tumour contrast, which may cause toxicity and contaminate the treatment
result. For this reason MR was used in this study to identify the tumour in addition to on-
board planar X-ray imaging.
Accurately delivering the microbeams to the targeted tumour site is necessary for the present
compact MRT device. The low dose rate makes it essential to confine the radiation area to
the tumour in order to minimize the total irradiation time. The results reported here
demonstrate that this can be accomplished using the presented combined MRI/X-ray image
guidance procedure. In the preliminary study, 11 out of the 13 analyzed animals received all
the prescribed microbeams on the targeted small brain tumours. Only two mice had
microbeams misplaced outside the tumour region. There remains much room for
improvement in this protocol, i.e. the microbeam alignment, animal fixation, image
registration and staining procedures, which would all contribute to a better targeting
accuracy. An affine registration algorithm for the brain histology section and MR image
alignment can potentially be implemented to provide more accurate evaluation of the
targeting errors. Also, if one mouse is irradiated at a time instead of two, CT images of the
mouse can be collected using the on-board micro-CT scanner for 3D registration with the
MRI to improve the registration accuracy.
Although still at a very early stage of the development, the present study demonstrates the
feasibility of image-guided microbeam irradiation using distributed carbon nanotube X-ray
source array technology. Targeted microbeam radiation with the energy, beam width, and
peak-valley-dose-ratio within the range considered necessary for the therapeutic effects
observed in the synchrotron MRT studies has been generated and delivered to live mice.
One limitation of the present first generation system is that its average dose rate is still too
low to deliver the high peak entrance dose considered necessary for tumour eradication
within the biologically reasonable time window of the mouse model. A second-generation
nanotube X-ray based microbeam irradiator is currently under construction, which will
provide a factor of 20 increase in the average dose rate over the present system. This will
enable targeted delivery of microbeams with peak dose matching the lower end of values
used in the synchrotron MRT studies.
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SolidWorks (Dassault Systems, France) drawing of an array of microplanar beams
traversing the mouse brain.
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Left: A photo of the irradiator surrounded by secondary shielding. Right: CAD drawing
showing the detailed configuration of the microbeam radiation therapy system with the
electron beam and X-ray beam indicated. The X-ray beam is collimated by a microbeam
collimator to an adjustable beamwidth.
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Illustration of the geometry of our prototype MRT system and dose rate measurements.
Dimensions were not drawn to scale. The effective focal line width on the anode after
projection is approximately 142 μm in width and 160 mm in length. The microbeam
collimator, made from two tungsten carbide parallels clamped against glass spacers, is at an
8 degree angle with respect to the anode surface, and the slit is 175 μm wide. The distance
from the centre of focal line to the bottom of the collimator is about 65.2 mm. The
divergence of the microplanar beam is around 0.15 degrees. For the dose rate measurement,
a piece of Gafchromic film was irradiated at 124 mm from the focal line for different
amounts of beam-on time.
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Left: SolidWorks drawing of our customized mouse head holder with ear bars. The nose
cone holder height can be adjusted based on the size and location of the mouse head. The
nose cone can be moved forward and backward to get the isoflurane to the mouse during the
irradiation. The pressure sensor is located underneath the abdomen of the mouse. Right: A
picture of a mouse under anaesthesia immobilized on the holder with a piece of gauze
wrapped around it to maintain its body temperature.
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A photo (top) and illustrations (middle and bottom) showing two mice imaged by X-ray
scanner in the image-and-shift manner, with only one mouse in the FOV at a time. The
double-stage enables vertical and horizontal adjustments.
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Diagram showing the geometric relations between the targeted tumour, landmark, and
microbeam locations. The y-direction is perpendicular to the paper plane. The microbeam
plane is in the y-z plane. Δx1 is the distance from the tumour to the ear bars measured in the
registered image, Δx2 is the distance of translation from the MRT chamber to the micro-CT,
and Δx3 is the distance between the centre of the ear bar and the alignment microbeam track
measured during microbeam alignment. The mouse holder with the Gafchromic film was
first irradiated for beam alignment, as shown on the left, and then translated to the right,
followed by mouse positioning and X-ray imaging.
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Left: The registered image showed two microbeams (indicated by red lines) planned to ‘cut
through’ the tumour region. The beam has a tilt of 8° from the collimator angle. Right: A
photo of two mice irradiated together in the MRT chamber shown with the heat lamp on to
maintain a certain body temperature during the radiation. The direction of the microbeam
plane and the entrance point are also indicated.
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Top: MR image of the mouse brain with the targeted tumour circled. Middle: X-ray
projection of the same animal showing the landmark ear bars and skull features. Bottom: X-
ray projection registered with MR image showing the relative position of the tumour and ear
bars.
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Beam patterns recorded by Gafchromic films at the entrance (top left) and exit (top right)
planes on the mouse head, and corresponding dose profiles (bottom) analyzed by
FilmQAPro program (using multi-channel dosimetry). The beam width at the entrance plane
is about 280 microns, and 380 microns at the exit plane. The PVDRs recorded for this
animal were roughly 16 at the entrance plane, and 15 at the exit plane.
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γ-H2AX staining of the sliced brain tissue with three microbeams of 48 Gy/beam (top left
and top right), two microbeams of 108 Gy/beam (bottom left), and a single microbeam of
138 Gy (bottom right). The images correspond to animal ID 1152 (top left), 1149 (top right),
1087 (bottom left), and 1089 (bottom right). The γ-H2AX foci-positive cells, shown as pink
strips, correspond to the microbeam pattern. The circled areas are tumour sites.
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γ-H2AX stained, sagittal image registered with MR projection for the same slice of tissue,
from two animals (Left: ID 1152 and right: ID 1145) irradiated with three microbeams of 48
Gy/beam. Microbeam tracks are the pink strips through the higher contrast tumour region,
demarcated by the yellow circle. The targeting error was measured from the microbeam
location to the targeted tumour centre.
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MRI/X-ray radiograph combined image-guided MRT procedure.
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Table 1
Summary of the targeting uncertainties.




Number of MBs with peakentrance dose per beam
1087 290 390 Two beams, 108 Gy/beam
1086 800 1000 Single beam, 138 Gy/beam
1089 10 50 Single beam, 138 Gy/beam
1123 100 100 Three beams, 48 Gy/beam
1122 80 330 Three beams, 48 Gy/beam
1141 830 660 Three beams, 48 Gy/beam
1140 300 440 Three beams, 48 Gy/beam
1145 660 790 Three beams, 48 Gy/beam
1151 100 100 Three beams, 48 Gy/beam
1150 1130 1600 Three beams, 48 Gy/beam
1153 90 100 Three beams, 48 Gy/beam
1152 230 140 Three beams, 48 Gy/beam
1149 1280 1280 Three beams, 48 Gy/beam
Average 454 537 --
Standard Deviation 417 482 --
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